Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

7:23 PM ET Form 4
Insider Selling Schwab Charles Corp SCHW

Schwab Charles Co-Chairman Charles R. Schwab Sells $18.1M of Stock

Charles R. Schwab, Co-Chairman, sold 203,150 shares of Schwab Charles Corp at $88.36 to $89.50 a share (average $89.12) in 2 transactions, worth $18.1M in total between Oct 28, 2026 and Oct 29, 2026. Shares held after the trade: 53,346,291 (-0.3%).

Value
$18.1M
Shares
203,150
Average price
$89.12
Role
Co-Chairman
Holding change
-0.3%
Trade date
Oct 28, 2026 to Oct 29, 2026
7:04 PM ET Form 4
Insider Buying Ares Capital Corp ARCC

Ares Capital Insider Mary Beth Henson Buys $46.1K of Stock

Mary Beth Henson bought 2,500 shares of Ares Capital Corp at $18.46 a share, worth $46.1K in total on Oct 28, 2026. Shares held after the trade: 36,969 (+7.3%).

Value
$46.1K
Shares
2,500
Price
$18.46
Holding change
+7.3%
Trade date
Oct 28, 2026
6:47 PM ET Form 4
Insider Selling Samsara Inc. IOT

Samsara CEO Sanjit Biswas Sells $11.3M of Stock

Sanjit Biswas, CEO, sold 263,600 shares of Samsara Inc. at $41.39 to $44.91 a share (average $42.93) in 13 transactions, worth $11.3M in total between Oct 27, 2026 and Oct 29, 2026. Shares held after the trade: 461,835 (-3.6%).

Value
$11.3M
Shares
263,600
Average price
$42.93
Role
CEO
Holding change
-3.6%
Trade date
Oct 27, 2026 to Oct 29, 2026
6:47 PM ET Form 4
Insider Selling Kestra Medical Technologies, Ltd. KMTS

Kestra Medical Technologies CFO Vaseem Mahboob Sells $2.41M of Stock

Vaseem Mahboob, CFO, sold 79,500 shares of Kestra Medical Technologies, Ltd. at $30.04 to $30.60 a share (average $30.30) in 3 transactions, worth $2.41M in total between Oct 27, 2026 and Oct 29, 2026. Shares held after the trade: 60,609 (-7.3%).

Value
$2.41M
Shares
79,500
Average price
$30.30
Role
CFO
Holding change
-7.3%
Trade date
Oct 27, 2026 to Oct 29, 2026
6:46 PM ET Form 4
Insider Selling Samsara Inc. IOT

Samsara Insider John Bicket Sells $11.3M of Stock

John Bicket sold 263,900 shares of Samsara Inc. at $41.45 to $44.97 a share (average $42.92) in 13 transactions, worth $11.3M in total between Oct 27, 2026 and Oct 29, 2026. Shares held after the trade: 561,398 (-2.3%).

Value
$11.3M
Shares
263,900
Average price
$42.92
Holding change
-2.3%
Trade date
Oct 27, 2026 to Oct 29, 2026
6:44 PM ET Form 4
Insider Selling Kestra Medical Technologies, Ltd. KMTS

Kestra Medical Technologies Insider Traci S. Umberger Sells $901K of Stock

Traci S. Umberger sold 30,000 shares of Kestra Medical Technologies, Ltd. at $30.03 a share, worth $901K in total on Oct 27, 2026. Shares held after the trade: 195,825 (-13.3%).

Value
$901K
Shares
30,000
Price
$30.03
Holding change
-13.3%
Trade date
Oct 27, 2026
6:30 PM ET Form 4
Insider Selling Apple Inc. AAPL

Apple SVP, GC and Government Affairs Jennifer Newstead Sells $824K of Stock

Jennifer Newstead, SVP, GC and Government Affairs, sold 2,399 shares of Apple Inc. at $343.36 a share, worth $824K in total on Oct 27, 2026. Shares held after the trade: 32,396 (-6.9%).

Value
$824K
Shares
2,399
Price
$343.36
Role
SVP, GC and Government Affairs
Holding change
-6.9%
Trade date
Oct 27, 2026
6:30 PM ET Form 4
Insider Selling Keycorp KEY

Keycorp Head of Institutional Bank Andrew J. Paine III Sells $830K of Stock

Andrew J. Paine III, Head of Institutional Bank, sold 39,130 shares of Keycorp at $21.20 a share, worth $830K in total on Oct 28, 2026. Shares held after the trade: 191,571 (-17.0%).

Value
$830K
Shares
39,130
Price
$21.20
Role
Head of Institutional Bank
Holding change
-17.0%
Trade date
Oct 28, 2026
6:21 PM ET Form 4
Insider Buying Boundless Bio, Inc. BOLD

Boundless Bio 10% Owner Kevin Tang Buys $25.7K of Stock

Kevin Tang, 10% Owner, bought 10,707 shares of Boundless Bio, Inc. at $2.40 a share, worth $25.7K in total on Oct 27, 2026. Shares held after the trade: 3,022,456 (+0.4%).

Value
$25.7K
Shares
10,707
Price
$2.40
Role
10% Owner
Holding change
+0.4%
Trade date
Oct 27, 2026
6:18 PM ET Form 4
Insider Selling Sierra Bancorp BSRR

Sierra Bancorp Insider Lynda Scearcy Sells $248K of Stock

Lynda Scearcy sold 5,850 shares of Sierra Bancorp at $42.34 a share, worth $248K in total on Oct 29, 2026. Shares held after the trade: 24,283 (-19.4%).

Value
$248K
Shares
5,850
Price
$42.34
Holding change
-19.4%
Trade date
Oct 29, 2026
6:15 PM ET Form 4
Insider Selling Sierra Bancorp BSRR

Sierra Bancorp President/CEO Kevin J. McPhaill Sells $171K of Stock

Kevin J. McPhaill, President/CEO, sold 4,000 shares of Sierra Bancorp at $42.85 a share, worth $171K in total on Oct 29, 2026. Shares held after the trade: 63,807 (-5.9%).

Value
$171K
Shares
4,000
Price
$42.85
Role
President/CEO
Holding change
-5.9%
Trade date
Oct 29, 2026
6:11 PM ET Form 4
Insider Selling Lindblad Expeditions Holdings, Inc. LIND

Lindblad Expeditions Holdings Director Sven-Olof Lindblad Sells $8.25M of Stock

Sven-Olof Lindblad, Director, sold 230,197 shares of Lindblad Expeditions Holdings, Inc. at $35.16 to $37.19 a share (average $35.86) in 6 transactions, worth $8.25M in total between Oct 27, 2026 and Oct 29, 2026. Shares held after the trade: 9,937,202 (-0.2%).

Value
$8.25M
Shares
230,197
Average price
$35.86
Role
Director
Holding change
-0.2%
Trade date
Oct 27, 2026 to Oct 29, 2026
6:11 PM ET
Earnings Call Ingram Micro Holding Corp INGM ▶ Call

Ingram Micro Holding Earnings Call: Key Takeaways

Ingram Micro delivered record Q3 results with 21% revenue growth, driven by a 160% surge in AI infrastructure and GPU sales, leading to raised full-year guidance.

Call
Oct 29, 2026, 5:00 PM ET
6:03 PM ET Form 4
Insider Selling HP Inc HPQ

HP Pres Imaging Prtng & Solutions Anneliese Olson Sells $619K of Stock

Anneliese Olson, Pres Imaging Prtng & Solutions, sold 18,997 shares of HP Inc at $32.56 a share, worth $619K in total on Oct 29, 2026. Shares held after the trade: 169 (-99.1%).

Value
$619K
Shares
18,997
Price
$32.56
Role
Pres Imaging Prtng & Solutions
Holding change
-99.1%
Trade date
Oct 29, 2026
6:00 PM ET Form 4
Insider Selling Enova International, Inc. ENVA

Enova International Chief Strategy Officer Kirk Chartier Sells $4.8M of Stock

Kirk Chartier, Chief Strategy Officer, sold 27,977 shares of Enova International, Inc. at $171.51 a share, worth $4.8M in total on Oct 27, 2026. Shares held after the trade: 76,995 (-26.7%).

Value
$4.8M
Shares
27,977
Price
$171.51
Role
Chief Strategy Officer
Holding change
-26.7%
Trade date
Oct 27, 2026
6:00 PM ET Form 4
Insider Selling Enova International, Inc. ENVA

Enova International Executive Chairman David Fisher Sells $4.04M of Stock

David Fisher, Executive Chairman, sold 23,157 shares of Enova International, Inc. at $171.79 to $178.16 a share (average $174.53) in 2 transactions, worth $4.04M in total between Oct 27, 2026 and Oct 28, 2026. Shares held after the trade: 306,444 (-3.1%).

Value
$4.04M
Shares
23,157
Average price
$174.53
Role
Executive Chairman
Holding change
-3.1%
Trade date
Oct 27, 2026 to Oct 28, 2026
6:00 PM ET Form 4
Insider Selling Enova International, Inc. ENVA

Enova International CEO Steven E. Cunningham Sells $2.63M of Stock

Steven E. Cunningham, CEO, sold 15,305 shares of Enova International, Inc. at $172.00 a share, worth $2.63M in total on Oct 27, 2026. Shares held after the trade: 118,789 (-3.4%).

Value
$2.63M
Shares
15,305
Average price
$172.00
Role
CEO
Holding change
-3.4%
Trade date
Oct 27, 2026
5:48 PM ET Form 4
Insider Buying New Germany Fund Inc GF

New Germany Fund Insider Saba Capital Management L.P. Buys $25.5K of Stock

Saba Capital Management L.P. bought 2,504 shares of New Germany Fund Inc at $10.20 a share, worth $25.5K in total on Oct 28, 2026. Shares held after the trade: 3,903,924 (+0.1%).

Value
$25.5K
Shares
2,504
Price
$10.20
Holding change
+0.1%
Trade date
Oct 28, 2026
5:47 PM ET Form 4
Insider Selling Dime Commercial Bancshares, Inc. DCOM

Dime Commercial Bancshares Director Basswood Capital Management L.L.C. Sells $1.31M of Stock

Basswood Capital Management L.L.C., Director, sold 30,988 shares of Dime Commercial Bancshares, Inc. at $42.02 to $42.51 a share (average $42.42) in 10 transactions, worth $1.31M in total between Oct 27, 2026 and Oct 29, 2026. Shares held after the trade: 369,832 (-0.2%).

Value
$1.31M
Shares
30,988
Average price
$42.42
Role
Director
Holding change
-0.2%
Trade date
Oct 27, 2026 to Oct 29, 2026
5:39 PM ET Form 4
Insider Buying BNY Mellon Strategic Municipal Bond Fund, Inc. DSM

BNY Mellon Strategic Municipal Bond Fund Insider Saba Capital Management L.P. Buys $10.8K of Stock

Saba Capital Management L.P. bought 1,992 shares of BNY Mellon Strategic Municipal Bond Fund, Inc. at $5.43 a share, worth $10.8K in total on Oct 28, 2026. Shares held after the trade: 5,472,376 (+0.0%).

Value
$10.8K
Shares
1,992
Price
$5.43
Holding change
+0.0%
Trade date
Oct 28, 2026
5:32 PM ET Form 4
Insider Buying Japan Smaller Capitalization Fund Inc JOF

Japan Smaller Capitalization Fund Insider Saba Capital Management L.P. Buys $182K of Stock

Saba Capital Management L.P. bought 15,967 shares of Japan Smaller Capitalization Fund Inc at $11.38 a share, worth $182K in total on Oct 28, 2026. Shares held after the trade: 2,758,343 (+0.6%).

Value
$182K
Shares
15,967
Price
$11.38
Holding change
+0.6%
Trade date
Oct 28, 2026
5:28 PM ET 8-K
Leadership Change Estrella Immunopharma, Inc. ESLA

Estrella Immunopharma Leadership Change

Estrella Immunopharma appointed Cynthia Pussinen as Chief Executive Officer and Chairperson of the Board, effective October 25, 2026. She succeeds Cheng Liu, Ph.D., who transitioned to the role of Chief Scientific Officer while remaining President and a director. Ms. Pussinen's employment agreement includes an initial base salary of $250,000 with automatic increases tied to future funding milestones.

5:27 PM ET 8-K
Capital Raise T3 Defense Inc. DFNS

T3 Defense Capital Raise of $10M

T3 Defense Inc. raised $10 million in gross proceeds through a private placement of 200 units to an accredited investor. Each unit consists of one share of Series B Convertible Preferred Stock and warrants to purchase 14,851 shares of common stock. The company received net proceeds of approximately $6.6 million after deducting placement agent fees and the repayment of an existing term note.

Value
$10M
Counterparty
Dawson James Securities Inc.
5:26 PM ET 8-K
Business Update Dermata Therapeutics, Inc. DRMA

Dermata Therapeutics Business Update

Dermata Therapeutics announced the enrollment of the first participant in a clinical trial for Tome Clearing Treatment, its once-weekly acne treatment. The company expects to launch this product commercially in the first half of 2027 as part of its strategic shift toward skincare products.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.